Elevated miR‐122 serum levels are an independent marker of liver injury in inflammatory diseases
Christoph Roderburg(Universitätsklinikum Aachen), Tom Luedde(Heinrich Heine University Düsseldorf), Joern Janssen(RWTH Aachen University), Fabian Benz(RWTH Aachen University), David Vargas Cardenas(RWTH Aachen University), Karina Kreggenwinkel(RWTH Aachen University), Jérémie Gautheron(Inserm), Alexander Koch(RWTH Aachen University), Mihael Vucur(Düsseldorf University Hospital), Frank Tacke(Charité - Universitätsmedizin Berlin), Anne T. Schneider(Düsseldorf University Hospital), Christiane Koppe(RWTH Aachen University), Henning W. Zimmermann(Sankt-Antonius-Hospital Eschweiler), Mark Luedde(Christian-Albrechts-Universität zu Kiel), Christian Trautwein(TUM Klinikum)
Cited by 114
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.4k
Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis
|Hepatology|2010|786